ANGO
Price
$8.81
Change
+$0.12 (+1.38%)
Updated
Dec 26, 01:13 PM (EDT)
7 days until earnings call
TFX
Price
$175.55
Change
-$1.71 (-0.96%)
Updated
Dec 26, 10:30 AM (EDT)
56 days until earnings call
Ad is loading...

ANGO vs TFX

Header iconANGO vs TFX Comparison
Open Charts ANGO vs TFXBanner chart's image
AngioDynamics
Price$8.81
Change+$0.12 (+1.38%)
Volume$404
CapitalizationN/A
Teleflex
Price$175.55
Change-$1.71 (-0.96%)
Volume$300
CapitalizationN/A
ANGO vs TFX Comparison Chart
Loading...
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANGO vs. TFX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a Buy and TFX is a Buy.

COMPARISON
Comparison
Dec 26, 2024
Stock price -- (ANGO: $8.69 vs. TFX: $177.26)
Brand notoriety: ANGO and TFX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANGO: 24% vs. TFX: 24%
Market capitalization -- ANGO: $233.95M vs. TFX: $10.49B
ANGO [@Medical Specialties] is valued at $233.95M. TFX’s [@Medical Specialties] market capitalization is $10.49B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANGO’s FA Score shows that 0 FA rating(s) are green whileTFX’s FA Score has 2 green FA rating(s).

  • ANGO’s FA Score: 0 green, 5 red.
  • TFX’s FA Score: 2 green, 3 red.
According to our system of comparison, TFX is a better buy in the long-term than ANGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANGO’s TA Score shows that 5 TA indicator(s) are bullish while TFX’s TA Score has 5 bullish TA indicator(s).

  • ANGO’s TA Score: 5 bullish, 5 bearish.
  • TFX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TFX is a better buy in the short-term than ANGO.

Price Growth

ANGO (@Medical Specialties) experienced а -6.16% price change this week, while TFX (@Medical Specialties) price change was -0.57% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.09%. For the same industry, the average monthly price growth was +0.43%, and the average quarterly price growth was +3.74%.

Reported Earning Dates

ANGO is expected to report earnings on Apr 03, 2025.

TFX is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (+4.09% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TFX($10.5B) has a higher market cap than ANGO($234M). ANGO has higher P/E ratio than TFX: ANGO (44.84) vs TFX (29.48). ANGO YTD gains are higher at: 10.842 vs. TFX (-28.452). TFX has higher annual earnings (EBITDA): 761M vs. ANGO (-28.49M). TFX has more cash in the bank: 223M vs. ANGO (60.9M). ANGO has less debt than TFX: ANGO (4.73M) vs TFX (1.93B). TFX has higher revenues than ANGO: TFX (2.97B) vs ANGO (330M).
ANGOTFXANGO / TFX
Capitalization234M10.5B2%
EBITDA-28.49M761M-4%
Gain YTD10.842-28.452-38%
P/E Ratio44.8429.48152%
Revenue330M2.97B11%
Total Cash60.9M223M27%
Total Debt4.73M1.93B0%
FUNDAMENTALS RATINGS
ANGO vs TFX: Fundamental Ratings
ANGO
TFX
OUTLOOK RATING
1..100
9377
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9883
PRICE GROWTH RATING
1..100
3864
P/E GROWTH RATING
1..100
6131
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (18) in the Medical Specialties industry is somewhat better than the same rating for ANGO (69). This means that TFX’s stock grew somewhat faster than ANGO’s over the last 12 months.

TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ANGO (100). This means that TFX’s stock grew similarly to ANGO’s over the last 12 months.

TFX's SMR Rating (83) in the Medical Specialties industry is in the same range as ANGO (98). This means that TFX’s stock grew similarly to ANGO’s over the last 12 months.

ANGO's Price Growth Rating (38) in the Medical Specialties industry is in the same range as TFX (64). This means that ANGO’s stock grew similarly to TFX’s over the last 12 months.

TFX's P/E Growth Rating (31) in the Medical Specialties industry is in the same range as ANGO (61). This means that TFX’s stock grew similarly to ANGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANGOTFX
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 4 days ago
60%
Declines
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 11 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
55%
Aroon
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
68%
View a ticker or compare two or three
Ad is loading...
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA462.2831.68
+7.36%
Tesla
AAPL258.202.93
+1.15%
Apple
SPY601.306.61
+1.11%
SPDR® S&P 500® ETF Trust
GME31.140.24
+0.78%
GameStop Corp
BTC.X99299.195000623.101560
+0.63%
Bitcoin cryptocurrency

ANGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with CNMD. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then CNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
-1.92%
CNMD - ANGO
40%
Loosely correlated
+1.71%
HBIO - ANGO
39%
Loosely correlated
-0.95%
TFX - ANGO
39%
Loosely correlated
-0.56%
FLGT - ANGO
35%
Loosely correlated
-0.43%
NVST - ANGO
35%
Loosely correlated
+0.80%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with SNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then SNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
-0.56%
SNN - TFX
57%
Loosely correlated
-0.41%
COO - TFX
49%
Loosely correlated
+0.31%
MDT - TFX
48%
Loosely correlated
+0.17%
ICUI - TFX
48%
Loosely correlated
+1.42%
PRCT - TFX
45%
Loosely correlated
+3.17%
More